Zobrazeno 1 - 9
of 9
pro vyhledávání: '"DANIEL DOLEZAL"'
Autor:
Martina Sterclova, Martina Doubkova, Lubica Sykorova, Vladimir Bartos, Monika Zurkova, Vladimira Lostakova, Radka Mokosova, Martina Plackova, Ladislav Lacina, Michaela Cimrova, Radka Bittenglova, Pavlina Lisa, Pavla Musilova, Daniel Dolezal, Jana Psikalova, Petra Ovesna, Martina Koziar Vasakova
Publikováno v:
Pulmonary Medicine, Vol 2024 (2024)
There are limited data on referral rates and the number of patients with idiopathic pulmonary fibrosis (IPF) who are eligible for lung transplantation. The aim of the present study was to assess adherence to the consensus of the International Society
Externí odkaz:
https://doaj.org/article/94d509ca7d934c66ba732b7f4a1dc771
Prognostic Value ofEGFRExon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer
Autor:
Marketa Cernovska, Leona Koubková, Kristina Sandstrom, Jana Krejčí, Martin Svaton, Monika Bratová, Jiri Blazek, Jana Skrickova, P. Opálka, Helena Čoupková, Michal Hrnčiarik, Ondrej Fischer, Karolina Hurdalkova, Daniel Dolezal, Tana Tuzova, Magda Barinova, Milada Zemanova, Péter Kunovszki, Lubos Holubec, Miloš Pešek, P. Mahadevia
Publikováno v:
Anticancer Research. 41:5625-5634
Background/aim Per literature, patients with epidermal growth factor receptor (EGFR) exon-20 insertions respond poorly to tyrosine kinase inhibitors (TKIs). This study analyzed real-world data to examine the prognostic and predictive value of these m
Autor:
Magda Barinova, Jana Skrickova, P. Opálka, Miloš Pešek, M. Černovská, Martin Safanda, Karolina Hurdalkova, Helena Coupkova, Martin Svaton, Daniel Krejci, Milada Zemanova, Monika Bratová, Michal Hrnčiarik, Daniel Dolezal, J. Krejčí, Petra Zemanova, Leona Koubková, Juraj Kultan, Ondrej Fischer
Publikováno v:
Anticancer Research. 41:2597-2603
Background/aim Platinum-based chemotherapy with pemetrexed or paclitaxel/bevacizumab are regimens used in combination with checkpoint inhibitors in non-squamous non-small cell lung cancer (NSCLC) treatment. We conducted a real-world study to compare
Autor:
Monika Bratová, Daniel Dolezal, Michal Hrnčiarik, Marketa Cernovska, Magda Barinova, Tana Tuzova, Milada Zemanova, Martin Svaton, Ondrej Fischer, Jana Krejčí, Helena Čoupková, Jana Skrickova, Karolina Hurdalkova, Bedrich Porzer, Leona Koubková
Publikováno v:
Anticancer Research. 41:2059-2065
Background/Aim: We investigated efficacy differences for afatinib versus gefitinib in non-small-cell lung cancer (NSCLC) according to epidermal growth factor receptor (EGFR) mutations. Patients and Methods: We retrospectively analysed data for 343 pa
Autor:
MARTIN SVATON, MONIKA BRATOVA, LEONA KOUBKOVA, ONDREJ FISCHER, BOHUSLAV MELICHAR, MICHAL HRNCIARIK, DANIEL DOLEZAL, ONDREJ BILEK, JANA KREJCI, MARIE DROSSLEROVA, ZDENKA DLOUHA, JIRI BLAZEK, PETRA MAJKOVA, LUCIE BROZOVA, MAREK STASTNY
Publikováno v:
Anticancer research. 42(4)
This study compared the results of nivolumab treatment in patients with pulmonary adenocarcinomas based upon previous chemotherapeutic regimens.The data source for this retrospective study was the Czech VILP registry of patients with nivolumab-treate
Autor:
Martin Svaton, Michal Hrnčiarik, Leona Koubková, Jana Skrickova, Monika Bratová, Daniel Dolezal, Jana Krejčí, Libor Havel, Martin Safanda, Helena Čoupková, Magda Barinova, Marketa Cernovska, Juraj Kultan, Kristián Brat, Ondrej Fischer, Tana Tuzova, Milada Zemanova, Karolina Hurdalkova, Miloš Pešek
Publikováno v:
Lung cancer.
Publikováno v:
Journal of burn careresearch : official publication of the American Burn Association. 43(1)
Burn injury is one of the most serious traumatic events with possible psychological and psychosocial consequences. Health status perception is one of the main health outcomes. The severity of psychological symptoms does not always correlate with that
Autor:
Martin, Svaton, Monika, Bratova, Ondrej, Fischer, Jana, Krejci, Leona, Koubkova, Marketa, Cernovska, Michal, Hrnciarik, Milada, Zemanova, Helena, Coupkova, Bedrich, Porzer, Daniel, Dolezal, Tana, Tuzova, Karolina, Hurdalkova, Magda, Barinova, Jana, Skrickova
Publikováno v:
Anticancer research. 41(4)
We investigated efficacy differences for afatinib versus gefitinib in non-small-cell lung cancer (NSCLC) according to epidermal growth factor receptor (EGFR) mutations.We retrospectively analysed data for 343 patients with NSCLC with performance stat
Autor:
Daniel Doležal
Publikováno v:
Knihopis, K02061